x

Coronavirus

France Stopped the Use of Hydroxychloroquine for Treating COVID-19 Patients

PARIS — The French government has stopped the use of malaria drug hydroxychloroquine for treating COVID-19 patients after a study suggested it doesn’t work and poses health risks.

A decree ending its use for the coronavirus in France was published Wednesday.

The World Health Organization did the same after a study of 100,000 patients worldwide published last week found the drug was ineffective against the virus and tied to a greater risk of death and heart rhythm problems.

The drug has been popular and politically sensitive in France, where it was included in a trial of multiple treatments and used on hospitalized patients.

U.S. President Donald Trump pushed hydroxychloroquine based on early research by prominent French virologist Dr. Didier Raoult suggesting it reduced virus symptoms.

Raoult shrugged off guidance from France’s High Council for Public Health to stop use of the drug, suggesting it’s not important now that the number of infected people is no longer at crisis levels. The council’s recommendation is “one opinion like any other, I don’t care much,” he told France’s LCI television Tuesday night.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

General News

PHILADELPHIA – The Federation of Hellenic Societies of Philadelphia and Greater Delaware Valley announced that the Evzones, the Presidential Guard of Greece will be participating in the Philadelphia Greek Independence Day Parade on March 20.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.